Washington Trust Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$979K Buy
1,064
+17
+2% +$17.2K 0.08% 114
2025
Q4
$1.12M Buy
1,047
+41
+4% +$39.2K 0.09% 109
2025
Q3
$767K Sell
1,006
-137
-12% -$102K 0.06% 125
2025
Q2
$891K Buy
1,143
+13
+1% +$10.1K 0.07% 105
2025
Q1
$933K Buy
1,130
+6
+0.5% +$4.99K 0.08% 101
2024
Q4
$867K Buy
1,124
+73
+7% +$60.4K 0.07% 105
2024
Q3
$931K Buy
1,051
+18
+2% +$16.2K 0.08% 101
2024
Q2
$935K Buy
1,033
+2
+0.2% +$1.6K 0.09% 98
2024
Q1
$802K Sell
1,031
-74
-7% -$52.7K 0.07% 106
2023
Q4
$644K Sell
1,105
-111
-9% -$64.8K 0.06% 112
2023
Q3
$653K Sell
1,216
-65
-5% -$33.5K 0.07% 111
2023
Q2
$601K Buy
1,281
+17
+1% +$7.13K 0.06% 114
2023
Q1
$434K Buy
1,264
+46
+4% +$15.5K 0.04% 127
2022
Q4
$446K Sell
1,218
-238
-16% -$84.4K 0.05% 125
2022
Q3
$471K Buy
1,456
+349
+32% +$111K 0.04% 136
2022
Q2
$358K Sell
1,107
-329
-23% -$98.8K 0.03% 152
2022
Q1
$411K Sell
1,436
-146
-9% -$37.6K 0.03% 166
2021
Q4
$437K Buy
+1,582
New +$401K 0.03% 172

Other funds holding LLY

Washington Trust Advisors's LLY Position: Q1 2026 in Review

Washington Trust Advisors increased its Eli Lilly (LLY) stake by 1.6% in Q1 2026, buying an estimated $17.2K and bringing the position to 1,064 shares worth $979K. The position accounts for 0.08% of the portfolio, ranked #114.

Washington Trust Advisors first reported a position in LLY in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.12M in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Washington Trust Advisors held 1,064 shares of Eli Lilly worth $979K as of Q1 2026.
  • Washington Trust Advisors bought 17 Eli Lilly shares in Q1 2026, an estimated $17.2K.
  • Eli Lilly made up 0.08% of Washington Trust Advisors's portfolio in Q1 2026, its #114 holding.
  • Washington Trust Advisors first reported a position in Eli Lilly in Q4 2021 and has held it in 18 quarters since.
  • Washington Trust Advisors's Eli Lilly position peaked at $1.12M in Q4 2025.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Washington Trust Advisors's 13F filing for Q1 2026, filed 6 Apr 2026.